Philadelphia, 16 - 17 September 2025
Schedule
Create your personal agenda –check the favourite icon
Sep 168:55
Conference pass
Chair remarks
Keynotes
Julie Huxley-Jones, Vice President, Research, BSMO, Preclinical Technology, Vertex Pharmaceuticals
Sep 1610:00
Conference pass
Keynote Panel
Keynotes
Moderator: James Zanewicz, Chief Stratergy Officer, tulane university school of medicine
Sep 1611:40
Conference pass
Chair remarks
Rare Diseases in Genomics
Catherine Brownstein, Assistant Professor, Harvard Medical School
Sep 1611:40
Conference pass
Chair remarks
AI in Drug Development and Discovery
Sep 1611:40
Conference pass
Chair remarks
Bioinformatics + in silico R&D
Aridaman Pandit, Senior Principal Research Scientist (Director), AbbVie
Sep 1611:40
Conference pass
Chair remarks
Large Language Models
Paul Hanson, Vice President, Takeda
Sep 1611:40
Conference pass
Chair remarks
Big Data in Oncology
Samir Hanash, Director, Red And Charline Mccombs Institute For The Early Detection And Treatment Of Cancer, MD Anderson cancer center
Sep 1611:40
Conference pass
Chair remarks
Data Management, Storage and Architecture
Venkat Sanka, Data Analytics and Data Governance Consultant, Johnson & Johnson
Sep 1611:40
Conference pass
Chair remarks
Data Integration + FAIR
Vrushali Raut, Sr. IT Manager, Gilead Sciences
Sep 1611:40
Conference pass
Sep 1611:45
Conference pass
Rare disease discovery infrastructure at a tertiary children’s hospital
Rare Diseases in Genomics
Catherine Brownstein, Assistant Professor, Harvard Medical School
Sep 1611:45
Conference pass
Harnessing the Power of Generative AI: Unlocking Insights from Real-World Data for Data-Driven Decisions in Pharma R&D
AI in Drug Development and Discovery
Sep 1611:45
Conference pass
Utilizing large-scale biobank-based human circulating proteomics and genetics to enhance novel therapeutic target discovery
Bioinformatics + in silico R&D
Yi-Hsiang Hsu, Director and associate Professor, Broad Institute of MIT and Harvard
Sep 1611:45
Conference pass
From Data to Diagnosis: The Impact of Large Language Models in Medical AI
Large Language Models
Hemachandran Kannan, Director, Woxsen University
Sep 1611:45
Conference pass
Risk assessment for prevention
Big Data in Oncology
Samir Hanash, Director, Red And Charline Mccombs Institute For The Early Detection And Treatment Of Cancer, MD Anderson cancer center
Sep 1611:45
Conference pass
Digital transformation through co-pilots and agile upskilling
Digital Transformation
John Wright, Director of Engineering, Research and Development Informatics, Amgen
Sep 1611:45
Conference pass
Secondary use of data to generate insights
Data Management, Storage and Architecture
Christina Lu, Global Head Data Curation and Integration, Genentech
Sep 1611:45
Conference pass
A practical look at data governance in life sciences
Data Integration + FAIR
Jennifer Lee, Senior Vice President, Novita Pharmaceuticals
Sep 1611:45
Conference pass
Intelligent Trials: How AI is Redefining the Clinical Research Landscape
AI in Clinical Trials
Sep 1611:45
Conference pass
Preparing the biotech workforce of the future: the role of academic partnerships
Real World Evidence
Sep 1612:05
Conference pass
Project Bridge Proactive genetics: an AI tool to identify patients who would benefit from whole genome sequencing in the outpatient setting
Rare Diseases in Genomics
Matthew Bainbridge, Associate Director of Clinical Genomics Research, Rady Children's Institute for Genomic Medicine
Sep 1612:25
Conference pass
Strategic pipeline development and protaminase strategy for rare disease and integrative genomics
Rare Diseases in Genomics
Cynthia Brysch, Director of Quality Assurance and Regulatory Affairs, Horizon
Sep 1612:25
Conference pass
Biological sequence learning at GSK.AI
AI in Drug Development and Discovery
Ari Allyn-Feuer, Director of Artificial Intelligence Product, GSK
Sep 1612:25
Conference pass
Multi-omics and AI for target identification and validation
Bioinformatics + in silico R&D
Aridaman Pandit, Senior Principal Research Scientist (Director), AbbVie
Sep 1612:25
Conference pass
Applications of AI in global investigations
Large Language Models
Paul Hanson, Vice President, Takeda
Sep 1612:25
Conference pass
Oncology Translational Research with Real-World Data and Machine Learning: Study of Resistance to Immune Therapy in Non Small Cell Lung Cancer (NSCLC)
Big Data in Oncology
Paola Correa, Bioinformatics Specialist, Gilead Sciences
Sep 1612:25
Conference pass
AI-Driven Futures: Effective Strategies for Digital Transformation in Healthcare
Digital Transformation
Yaiza Peraza, Data Capabilities Lead, Novo Nordisk
Sep 1612:25
Conference pass
From Complexity to Clarity: Standardizing Data for Innovation in Biotech
Data Management, Storage and Architecture
Kenneth Schwartz, VP, Global Data, Genmab
Sep 1612:25
Conference pass
Pitfalls and Best Practices: Notes from the (research) field
Data Integration + FAIR
Lori Hoepner, Asst Professor, SUNY DOWNSTATE
Sep 1612:25
Conference pass
AI in Clinical Trials
AI in Clinical Trials
Preetha Ram, Managing Partner, Pier 70 Ventures
Sep 1612:25
Conference pass
Real-time prediction of postoperative adverse events in ICU
Real World Evidence
Qingchu Jin, Research Scientist, Northeastern university
Sep 1612:45
Conference pass
High-Throughput Drug Discovery for a Rare Neurological Disorder
Rare Diseases in Genomics
Alex Guin, Director, Computational Biology, Transcripta Bio
Sep 1613:05
Conference pass
Using genetic tools to find a cure for rare diseases
Rare Diseases in Genomics
Xiao Wang, Research Assistant Professor, Univeristy Of Pennsylvania
Sep 1613:05
Conference pass
Native Cell Membrane Nanoparticles System as a platform for membrane protein drug discovery
AI in Drug Development and Discovery
Sep 1613:05
Conference pass
Real World Applications of LLMs in Pharma Commercial
Large Language Models
Youssef Idelcaid, Head of AI Research Center, Drug Development, Gilead
Sep 1613:05
Conference pass
Harnessing Radiology and Radiomics Data for Data Science
Big Data in Oncology
Fengjian Shi, Product Owner - Oncology Data Science, AstraZencea
Sep 1613:05
Conference pass
Designing and developing R&D platforms
Data Management, Storage and Architecture
Sep 1613:05
Conference pass
Digital transformation in Aggregate Reporting
Digital Transformation
Rupesh Kumar Polupongu, Senior Manager, Global Safety Data Management, Otsuka Pharmaceutical
Sep 1613:05
Conference pass
Open access resources for genetic and genomic
Data Integration + FAIR
Noel Burtt, Director Of Operations, Diabetes Research, Broad Institute of M.I.T. & Harvard
Sep 1613:05
Conference pass
AI as a Powerful Ally: Empowering Clinical Professionals in Trials and Healthcare Research
AI in Clinical Trials
Sep 1613:05
Conference pass
Leveraging RWD in the Drug Development Process
Real World Evidence
Thomas Dougherty, Data Science & AI Innovative Partnership Lead, Novo Nordisk
Sep 1614:25
Conference pass
Chair remarks
Rare Diseases in Genomics
Sarath Babu Krishna Murthy, Director of Genomic Health & Informatics, Columbia university medical center
Sep 1614:25
Conference pass
Chair remarks
AI in Drug Development and Discovery
Sandra Barbosu, Associate Director, Information Technology and Innovation Foundation
Sep 1614:25
Conference pass
Chair remarks
Bioinformatics + in silico R&D
Abhijeet R Patil, Manager, Genomics and Computational Biology, Teva Pharmaceuticals
Sep 1614:25
Conference pass
Chair remarks
Large Language Models
Sairam Menon, Sr Manager, AI Product Group Engineering, J&J Innovative Medicine
Sep 1614:25
Conference pass
Chair remarks
Big Data in Oncology
Shuvayu Sen, VP and Head of Oncology VIOR, Merck & Co., Inc.
Sep 1614:25
Conference pass
Chair remarks
Digital Transformation
Soo Son, Health Equity Advocate, Unlocking Eve
Sep 1614:25
Conference pass
Chair remarks
Data Management, Storage and Architecture
Vikalp Khare, Director, US Head Safety Data Management, Otsuka Pharmaceutical
Sep 1614:25
Conference pass
Chair remarks
Data Integration + FAIR
Vrushali Raut, Sr. IT Manager, Gilead Sciences
Sep 1614:25
Conference pass
Chair remarks
AI in Clinical Trials
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Sep 1614:25
Conference pass
Speaker presentation
Real World Evidence
Rebecca Yee, Chief of Microbiology, Assistant Professor of Pathology, The George Washington University
Sep 1614:30
Conference pass
Data, AI and the patient advocate
Rare Diseases in Genomics
Neena Nizar, President and Founder, The Jansens Foundation
Sep 1614:30
Conference pass
Gen AI powering Medical and Patient Safety reviews
AI in Drug Development and Discovery
Sunil Talathi, Senior Director, Global Head - Data Science & AI, BeiGene
Sep 1614:30
Conference pass
Single cell genomics in drug discovery
Bioinformatics + in silico R&D
Abhijeet R Patil, Manager, Genomics and Computational Biology, Teva Pharmaceuticals
Sep 1614:30
Conference pass
Implementing GenAI Sustainably at Enterprise Scale
Large Language Models
Sairam Menon, Sr Manager, AI Product Group Engineering, J&J Innovative Medicine
Sep 1614:30
Conference pass
Leveraging pathology translational models for TLS detection in solid tumors
Big Data in Oncology
Meijian Guan, Associate Director Translational Data Science, Genmab
Sep 1614:30
Conference pass
Connected content driving digital transformation
Digital Transformation
Anthony Figorski, Senior Director, Business Transformation, AstraZeneca
Sep 1614:30
Conference pass
Safety Data Management
Data Management, Storage and Architecture
Vikalp Khare, Director, US Head Safety Data Management, Otsuka Pharmaceutical
Sep 1614:30
Conference pass
Developing a harmonized data ecosystem to accelerate cancer research at the Sylvester Comprehensive Cancer Center
Data Integration + FAIR
Vasileios Stathias, Assistant Director, Data Science, UNIVERSITY OF MIAMI
Sep 1614:30
Conference pass
Responsible AI
AI in Clinical Trials
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Sep 1614:30
Conference pass
Clinical utility of rapid diagnostics for antimicrobial resistance in infectious diseases
Real World Evidence
Rebecca Yee, Chief of Microbiology, Assistant Professor of Pathology, The George Washington University
Sep 1614:50
Conference pass
AI and clinical trials to automate the documentation process
AI in Clinical Trials
Chris Willis, Director, Emerging Method & Technologies - Research IT, Bristol Myers Squibb
Sep 1615:10
Conference pass
Unravelling the Rare: Advanced Genomic Approaches to Identifying Genetic Causes of Kidney Diseases
Rare Diseases in Genomics
Sarath Babu Krishna Murthy, Director of Genomic Health & Informatics, Columbia university medical center
Sep 1615:10
Conference pass
Quantum Computing beyond the hype - what is possible and when will it finally be useful?
AI in Drug Development and Discovery
Johannes Galatsanos, Researcher at Center of Quantum Networks, Massachusetts Institute of Technology
Sep 1615:10
Conference pass
Multi-Omics Strategies for Data-Driven Target Validation and Biomarker Identification
Bioinformatics + in silico R&D
Alex Pankov, Director, Head of Bioinformatics, ORIC pharmaceuticals
Sep 1615:10
Conference pass
GenAI at Scale: Driving Transformative Value and Impact in Medical Affairs
Large Language Models
Kausar Riaz Ahmed, Director, Generative AI Medical Engagement Lead, Pfizer
Sep 1615:10
Conference pass
DNA Methylation-Mediated Epigenetic Adaptation Promotes Cellular Resilience In AML
Big Data in Oncology
Manna Ahmed, Assistant Research Professor - Manager of The Genomics Resource Facility, Fox Chase Cancer Center
Sep 1615:10
Conference pass
Data and its architecture
Data Management, Storage and Architecture
Venkat Sanka, Data Analytics and Data Governance Consultant, Johnson & Johnson
Sep 1615:10
Conference pass
AI-powered multi-omics data integration for predictive modeling of drug actions
Data Integration + FAIR
Lei Xie, Professor, Hunter College of CUNY
Sep 1615:10
Conference pass
Clinical Trials in AI
AI in Clinical Trials
Ritesh Shah, Clinical Oncology Informatics Pharmacist, Penn Medicine
Sep 1615:10
Conference pass
Advancing the Clinical Trial Ecosystem: MENA’s Strategic Role in Enhancing Global Inclusivity
Real World Evidence
Huda Eldosougi, Chief Technical Advisor, Saudi food and drug authority
Sep 1615:30
Conference pass
Leveraging technology to revolutionise drug discovery and development
Digital Transformation
Ryan Pehrson, Head of Infrastructure & Cloud, Takeda
Sep 1615:50
Conference pass
Navigating launch challenges in rare disease markets
Rare Diseases in Genomics
Soumavo Sarkar, Director, Novartis
Sep 1615:50
Conference pass
LATTE: Federated Lossless Algorithms for Target Trial Emulation Using Decentralized Real-world Data For Drug Repurposing
AI in Drug Development and Discovery
Yong Chen, Professor of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania School Of Medicine
Sep 1615:50
Conference pass
Single cell approaches to tackle tumor clonality in AML
Bioinformatics + in silico R&D
Adam Karami, Head of Bioinformatics, Fels Cancer Institute of Personalized Medicine
Sep 1615:50
Conference pass
Generative AI driven clinical trials
Large Language Models
Kevin Lee, Senior Director of Biometrics and Data Science, Bristol Myers Squibb
Sep 1615:50
Conference pass
Translating big data into target optimization and discovery in oncology and beyond
Big Data in Oncology
Jenna Aronson, Principal, Two Bear Capital
Sep 1615:50
Conference pass
Digital transformation in AI
Digital Transformation
Richa Gulati, Senior Product Manager AI, Johnson & Johnson
Sep 1615:50
Conference pass
The Data Dilemma: Storage, Management, and the Privacy Puzzle
Data Management, Storage and Architecture
Joel Schwarz, Adjunct Law Professor, Cybersecurity and Privacy, Albany Law School
Sep 1615:50
Conference pass
Seamlessly Connecting the Dots: Advancing Data Integration for Precision Medicine and Drug Discovery
Data Integration + FAIR
Craig Stanley, VP Data Strategy and Technical Operations, Institute for Neurodegenerative Disorders
Sep 1615:50
Conference pass
AI in protocol authorization informing amendments and protocol optimizationAI in protocol authorization informing amendments and protocol optimization
AI in Clinical Trials
Mukul Virmani, Director, Clinical Data Science, Advanced Analytics, Gilead Sciences, Inc.
Sep 1615:50
Conference pass
The role of a control arm in rare disease therapy clinical trials
Real World Evidence
Mitra Tavakkoli, Executive Medical Director, Bridge Bio
Sep 1616:40
Conference pass
Chair remarks
Rare Diseases in Genomics
Sarath Babu Krishna Murthy, Director of Genomic Health & Informatics, Columbia university medical center
Sep 1616:40
Conference pass
Chair remarks
Bioinformatics + in silico R&D
Lana Garmire, Associate Professor, Univ of Michigan
Sep 1616:40
Conference pass
Sep 1616:40
Conference pass
Chair remarks
Big Data in Oncology
Shuvayu Sen, VP and Head of Oncology VIOR, Merck & Co., Inc.
Sep 1616:40
Conference pass
Chair remarks
Digital Transformation
Vivek Mukhatyar, GenAI Medical Engagement Lead, Pfizer
Sep 1616:40
Conference pass
Chair remarks
Data Management, Storage and Architecture
Venkat Sanka, Data Analytics and Data Governance Consultant, Johnson & Johnson
Sep 1616:40
Conference pass
Chair remarks
Data Integration + FAIR
Vrushali Raut, Sr. IT Manager, Gilead Sciences
Sep 1616:45
Conference pass
Publications and Medical Communications in the Digital Age and Post-Pandemic
Rare Diseases in Genomics
Sep 1616:45
Conference pass
Insilico approaches for repurposing drugs
AI in Drug Development and Discovery
Youyi Peng, Senior Bioinformatics Specialist, Rutgers University
Sep 1616:45
Conference pass
Personalized drug repurposing using spatial transcriptomics data
Bioinformatics + in silico R&D
Lana Garmire, Associate Professor, Univ of Michigan
Sep 1616:45
Conference pass
The journey of Takeda connected clinical systems and use of practical AI
Large Language Models
Harish Manmathan, Director of Clinical Data Engineering, Takeda
Sep 1616:45
Conference pass
AI based web applications for cancer-based diagnosis and usability gaging
Big Data in Oncology
Sep 1616:45
Conference pass
Digital transformation planning and stakeholder buy in
Digital Transformation
Sep 1616:45
Conference pass
Health Data as Infrastructure: Designing Interfaces for Trust Across Borders, Systems, and Generations
Data Management, Storage and Architecture
Linxin Gu, Founder and CEO, TechConnect
Sep 1616:45
Conference pass
The All of Us research programme - a platform to transform biomedical research
Data Integration + FAIR
Sep 1616:45
Conference pass
AI powered Clinical trial integration in the medical affairs field
AI in Clinical Trials
Sara Hammad, US Associate Medical Director - Transplantation, Sanofi
Sep 1616:45
Conference pass
Understanding complex diseases to identify the right targets
Real World Evidence
Michael Liebman, Managing Director and Co-Founder, IPQ Analytics, LLC
Sep 1617:05
Conference pass
Lab Automation & AI Accelerated Drug Discovery
Digital Transformation
Peter Clark, VP, Computational Drug Deaign, Novo Nordisk
Sep 1617:25
Conference pass
Data in rare disease and the changing landscape
Rare Diseases in Genomics
Moderator: Neena Nizar, President and Founder, The Jansens Foundation
Mitra Tavakkoli, Executive Medical Director, Bridge Bio
Molly Martell, Entrepreneur in Residence, Digital DX Ventures
Matthew Bainbridge, Associate Director of Clinical Genomics Research, Rady Children's Institute for Genomic Medicine
Steven Ferguson, Special Advisor, NIH Office of Technology Transfer
Sep 1617:25
Conference pass
Disease specific foundational models
AI in Drug Development and Discovery
Moderator: Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Sep 1617:25
Conference pass
Using bioinformatics + InSilco to optimise research and development
Bioinformatics + in silico R&D
Deidre Dalmas Wilk, Scientific Director, Global Investigative Safety, Nonclinical Safety Project Lead, GSK
Alex Guin, Director, Computational Biology, Transcripta Bio
MaryLena Bleile, Biomarker Statistician, Sanofi
Lana Garmire, Associate Professor, Univ of Michigan
Jake Chen, Endowed Professor and Founding Director, SPARC, University of Alabama at Birmingham
Sep 1617:25
Conference pass
Generative AI in healthcare
Large Language Models
Moderator: Abhishek Pandey, Global Lead and Principal Research Scientist II, AbbVie
Kausar Riaz Ahmed, Director, Generative AI Medical Engagement Lead, Pfizer
Kevin Lee, Senior Director of Biometrics and Data Science, Bristol Myers Squibb
Kritika Gulati, Corporate Faculty, Harrisburg University Of Science And Technology
Sally Wang Liang, Venture Partner, Highlight Capital
Sep 1617:25
Conference pass
Bringing together disbarred data in oncology
Big Data in Oncology
Moderator: Paul Petraro, Head Real-World Evidence Analytic COE, Global Medical Affairs, Boehringer Ingelheim Pharma Inc.
Jenna Aronson, Principal, Two Bear Capital
Sep 1617:25
Conference pass
Challenges in global systems implementation and integration
Data Management, Storage and Architecture
Joel Schwarz, Adjunct Law Professor, Cybersecurity and Privacy, Albany Law School
Linxin Gu, Founder and CEO, TechConnect
Vrushali Raut, Sr. IT Manager, Gilead Sciences
Sep 1617:25
Conference pass
Digital transformation in life science companies
Digital Transformation
Parag Dave, Head of Data, Digital, and Technology, Takeda
Sairam Menon, Sr Manager, AI Product Group Engineering, J&J Innovative Medicine
Sep 1617:25
Conference pass
Enhancing FAIR – Successes and Failures
Data Integration + FAIR
Moderator: Lori Hoepner, Asst Professor, SUNY DOWNSTATE
Jennifer Lee, Senior Vice President, Novita Pharmaceuticals
Sep 1617:25
Conference pass
Current regulatory standards within AI adoption and its reflection in clinical trial development and execution
AI in Clinical Trials
Moderator: Cynthia Brysch, Director of Quality Assurance and Regulatory Affairs, Horizon
Kevin Stevens, Head, Global Regulatory Affairs Device, PDT, Takeda
Vivek Suryanarayanan, Product Management, Takeda
Daya Shankar, Dean, School of Sciences, Woxsen University
Sep 1617:25
Conference pass
Leveraging RWE data to improve health equity
Real World Evidence
Moderator: Jin Lee, Investor, Oxford angel fund
Youssef Idelcaid, Head of AI Research Center, Drug Development, Gilead
Hong Truong, Principal, Define Ventures
Create your personal agenda –check the favourite icon
Sep 178:55
Conference pass
Sep 1711:40
Conference pass
Chair remarks
Data Integration + FAIR
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc
Sep 1711:40
Conference pass
Chair remarks
AI in Clinical Trials
Kate Luu, Associate Director, Data Scientist, Gilead Sciences
Sep 1711:40
Conference pass
Chair remarks
Innovation
Soumavo Sarkar, Director, Novartis
Sep 1711:45
Conference pass
Applications for future use of AI
AI in Drug Development and Discovery
Abhishek Pandey, Global Lead and Principal Research Scientist II, AbbVie
Sep 1711:45
Conference pass
Building AI Drug Discovery Capabilities in Academia
Bioinformatics + in silico R&D
Jake Chen, Endowed Professor and Founding Director, SPARC, University of Alabama at Birmingham
Sep 1711:45
Conference pass
Large language models for biomedical applications
Large Language Models
Hua Xu, Assistant Dean, Yale University School of Medicine
Sep 1711:45
Conference pass
Digital transformation in biotherapeutics discovery
Digital Transformation
Alexander Horspool, Associate Director of Data and Laboratory Automation in Biotherapeutics Discovery, Boehringer Ingelheim
Sep 1711:45
Conference pass
From Silos to Synergy: Building Scalable, FAIR Data Ecosystems in Biotech
Data Management, Storage and Architecture
Sep 1711:45
Conference pass
FAIR for the People: Change Management for Reluctant Participants
Data Integration + FAIR
FAIR-ification of data is an established goal in many industries, but managing the changes needed at the user level can be a challenge. Often, FAIR-enabling changes are made at the beginning of the pipeline, but the employees who benefit are at the end of it. What should you do to get everyone on board?
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc
Sep 1711:45
Conference pass
Optimizing clinical trial delivery with gen AI
AI in Clinical Trials
Vivek Suryanarayanan, Product Management, Takeda
Sep 1711:45
Conference pass
From Real-World Data to Real-World Evidence
Real World Evidence
Xiaozhou Fan, Sr. Director, Head of Real-World Evidence, Jazz Pharmaceuticals
Sep 1711:45
Conference pass
How we utilise AI in liquid biopsy
Precision Medicine and Liquid Biopsy
Raluca Predoiu, Companion Diagnostic Strategy Lead, AbbVie
Sep 1712:05
Conference pass
Approaches to precision therapeutics and clinical trial enhancements
Precision Medicine and Liquid Biopsy
Mary Helen Black, SVP and Head of Genomics, Foresite Labs
Sep 1712:25
Conference pass
Single cell genomics and large language models
Bioinformatics + in silico R&D
Qi Song, Senior Scientist, Bristol Myers Squibb
Sep 1712:25
Conference pass
Integration of LLMs with the drug discovery development
Large Language Models
Etai Jacob, Senior Director, Head of Data Science and AI, Early Oncology, AstraZeneca
Sep 1712:25
Conference pass
Digital twins into manufacturing
Digital Transformation
Parag Dave, Head of Data, Digital, and Technology, Takeda
Sep 1712:25
Conference pass
Visual strategies for accelerating drug discovery
Data Management, Storage and Architecture
Bang Wong, Sr Director, Business Engagement & Technology, Vertex pharmaceuticals
Sep 1712:25
Conference pass
Data integration for better decision making
Data Integration + FAIR
Sep 1712:25
Conference pass
AI and precision medicine for clinical trial development
AI in Clinical Trials
Yilin Xu, Head of clinical data analytics, AbbVie
Sep 1712:25
Conference pass
AI to advance the utility of real-world evidence
Real World Evidence
Hong Truong, Principal, Define Ventures
Sep 1712:25
Conference pass
Current state of precision medicine and liquid biopsy and where it is going
Precision Medicine and Liquid Biopsy
Jeffrey Lee, Associate Director of Cloud Architecture, Takeda
Sep 1712:25
Conference pass
Integrated precision medicine solutions for rare diseases
Innovation
Joshua Resnikoff, CEO and Cofounder, TMA Precision Health
Sep 1712:45
Conference pass
Prognostic Impact of MAGE-A4 Expression, HLA Subtype, and Patterns of Systemic Treatment in Patients with Metastatic Synovial Sarcoma: Implications for T-Cell Therapy
Real World Evidence
Sep 1713:05
Conference pass
Revolutionizing Drug Development: The Role of AI in Accelerating Discovery and Precision Medicine
AI in Drug Development and Discovery
Vineet Jain, IT Partner, Bristol Myers Squibb
Sep 1713:05
Conference pass
Causal reinforcement learning in drug development
Bioinformatics + in silico R&D
MaryLena Bleile, Biomarker Statistician, Sanofi
Sep 1713:05
Conference pass
Advancing Personalization in Healthcare Professional Omnichannel Communications
Digital Transformation
Donna Judd, Medical Channel Strategy & Engagement Lead, Pfizer
Sep 1713:05
Conference pass
Navigating R&D informatics
Data Integration + FAIR
Kyle Vick, Associate Director of Research Informatics, SpringWorks Therapeutics
Sep 1713:05
Conference pass
Applying machine learning to predict enrolment likelihood and clinical site
AI in Clinical Trials
Kate Luu, Associate Director, Data Scientist, Gilead Sciences
Sep 1713:05
Conference pass
Real world evidence in precision medicine development
Real World Evidence
Molly Martell, Entrepreneur in Residence, Digital DX Ventures
Sep 1713:05
Conference pass
Broadening participation in precision medicine and pharmacogenomics
Precision Medicine and Liquid Biopsy
Simeón Baker, Executive Director of External Affairs, Genomics England
Sep 1714:25
Conference pass
Chair remarks
Data Integration + FAIR
Philip Brown, Senior Data Engineer, Sanofi
Sep 1714:25
Conference pass
Chair remarks
AI in Clinical Trials
Kate Luu, Associate Director, Data Scientist, Gilead Sciences
Sep 1714:25
Conference pass
Chair remarks
Innovation
Soumavo Sarkar, Director, Novartis
Sep 1714:30
Conference pass
The road to clinical speech and language analysis
Large Language Models
Sep 1714:30
Conference pass
Game changing digital enabling tools, empowering seamless cross functional collaboration
Digital Transformation
Sep 1714:30
Conference pass
Electronic batch record data translation
Data Integration + FAIR
Philip Brown, Senior Data Engineer, Sanofi
Sep 1714:30
Conference pass
Application of machine learning methods in clinical trials for precision medicine
AI in Clinical Trials
Sep 1714:30
Conference pass
Study Visualization to support patient centricity
Real World Evidence
Betsy luo, IT Business Analyst, AstraZeneca
Sep 1714:30
Conference pass
Digital and computational pathology in clinical medicin
Precision Medicine and Liquid Biopsy
Nirmit Kumar, Senior Global Medical Strategy Leader, AstraZeneca
Sep 1714:50
Conference pass
Use cases for acceleration of clinical trials
Large Language Models
Amir Emadzadeh, Director, Genentech
Sep 1715:10
Conference pass
Harnessing AI to Bridge Skills Gaps and Drive Smart Biomanufacturing: Preparing the Biopharma Workforce for the Future of Drug Development
AI in Drug Development and Discovery
Sep 1715:10
Conference pass
Change management with generative AI
Large Language Models
Vivek Mukhatyar, GenAI Medical Engagement Lead, Pfizer
Sep 1715:10
Conference pass
Advancing care for animals in Zoetis through digital transformation
Digital Transformation
Susan Huse, Research Director, Zoetis
Sep 1715:10
Conference pass
Clinical trials implementation
Data Integration + FAIR
Sep 1715:10
Conference pass
Accelerated Approval Modeling in Clinical Trials
AI in Clinical Trials
Sep 1715:10
Conference pass
Generative AI applications using real world evidence
Real World Evidence
Matthew Foster, Executive Director, Technology, Strategy and Innovation, Amgen
Sep 1715:10
Conference pass
Potential paradigm shift in immune-oncology strategies: Synergistic combination of B-cell epitope peptide vaccines and immune checkpoint inhibitor (PD-1, PD-L1, CTLA-4, TIGIT and VEGF) vaccines
Precision Medicine and Liquid Biopsy
Pravin Kaumaya, Professor & Director, Indiana university School of Medicine
last published: 23/Apr/25 08:15 GMT
Get involved at BioTechX USA
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events